Integrated asparaginase development for biomedicine and food safety: from protein engineering to AlphaFold-guided oligomerization prediction

Anisa Fitri Rahayu , Dwi Wahyu Indriati , Dwi Wahyu Indriani , Endang Rinawati Purba , Naswandi Nur

Systems Microbiology and Biomanufacturing ›› 2026, Vol. 6 ›› Issue (5) : 141

PDF
Systems Microbiology and Biomanufacturing ›› 2026, Vol. 6 ›› Issue (5) :141 DOI: 10.1007/s43393-026-00533-w
Review
review-article
Integrated asparaginase development for biomedicine and food safety: from protein engineering to AlphaFold-guided oligomerization prediction
Author information +
History +
PDF

Abstract

Asparaginase (ASNase), an enzyme that hydrolyzes l-asparagine into l-aspartic acid and ammonia, represents an essential biocatalyst at the interface of biomedicine and food safety. Clinically, ASNase is a cornerstone therapy for acute lymphoblastic leukemia (ALL), while in the food industry it is widely applied to reduce acrylamide formation, thereby lowering neurotoxic and carcinogenic risks without compromising product quality. However, despite separate advancements in using ASNase for cancer therapy and food safety, an integrated optimization strategy is still lacking. Since both applications rely on the same catalytic mechanism, require good biochemical properties (e.g., Km, Kcat, Vmax, and half-life), and share critical production safety concerns, a dual-purpose enzyme could be engineered for both applications. This review bridges this development gap by proposing an integrated framework that unifies structure–function analysis and protein engineering strategies for both applications, enabling cost- and time-efficient workflows starting with bioinformatic evaluation. Ultimately, this review outlines strategies to engineer ASNase variants with enhanced catalytic efficiency, stability, and reusability, alongside reduced glutaminase co-activity and immunogenicity. This review evaluates emerging approaches, including humanized design, rational engineering, AlphaFold 3-based structural and dimerization predictions, and encapsulation, alongside advanced fermentation platforms for cost-effective and large-scale production. By assessing the correlations between enzymatic potency, structure–function relationships, immunogenicity, and industrial viability, this multidisciplinary work integrates bioengineering, computational modeling, and fermentation development to guide future ASNase innovations in healthcare and the food industry.

Graphical abstract

Keywords

Asparaginase / Acrylamide / Food safety / Acute lymphoblastic leukemia (ALL) / Protein engineering / AlphaFold 3

Cite this article

Download citation ▾
Anisa Fitri Rahayu, Dwi Wahyu Indriati, Dwi Wahyu Indriani, Endang Rinawati Purba, Naswandi Nur. Integrated asparaginase development for biomedicine and food safety: from protein engineering to AlphaFold-guided oligomerization prediction. Systems Microbiology and Biomanufacturing, 2026, 6 (5) : 141 DOI:10.1007/s43393-026-00533-w

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Abakumova OI, Podobed OV, Karalkin PA, Kondakova LI, Sokolov NN. Antitumor activity of L-asparaginase from Erwinia carotovora from against different leukemic and solid tumours cell lines. Biomed Khim, 2013, 59: 498-513

[2]

Abdelrazek NA, Saleh SE, Raafat MM, Ali AE, Aboulwafa MM. Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297. AMB Express, 2024

[3]

Abdullah EM, Khan MS, Aziz IM, Alokail MS, Karthikeyan S, et al.. Expression, characterization and cytotoxicity of recombinant L-asparaginase II from Salmonella paratyphi cloned in Escherichia coli. Int J Biol Macromol, 2024

[4]

Abramson J, Adler J, Dunger J, Evans R, Green T, et al.. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 2024

[5]

Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR, et al.. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood, 2000, 96: 1709-1715

[6]

Aishwarya SS, Iyappan S, Vijaya LK, Rajnish KN. In silico analysis, molecular cloning, expression and characterization of l-asparaginase gene from Lactobacillus reuteri DSM 20016. 3 Biotech, 2017

[7]

Aishwarya SS, Selvarajan E, Iyappan S, Rajnish KN. Recombinant L-asparaginase II from Lactobacillus casei subsp. casei ATCC 393 and its anticancer activity. Indian J Microbiol, 2019, 59: 313-320

[8]

Aiswarya R, Baskar G. Enzymatic mitigation of acrylamide in fried potato chips using asparaginase from Aspergillus terreus. Int J Food Sci Technol, 2018, 53: 491-498

[9]

Akahane K, Kimura S, Miyake K, Watanabe A, Kagami K, et al.. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL. Blood Adv, 2022, 6(1212-224

[10]

Al Yousef SA. Fusarium sp. L-asparaginases: purification, characterization, and potential assessment as an antileukemic chemotherapeutic agent. Environ Sci Pollut Res, 2022, 29: 11243-11254

[11]

Al-Mahayri ZN, AlAhmad MM, Ali BR. Long-term effects of pediatric acute lymphoblastic leukemia chemotherapy: Can recent findings ınform old strategies?. Front Oncol, 2021

[12]

Alrumman SA, Mostafa YS, Al-Izran KA, Alfaifi MY, Taha TH, et al.. Production and anticancer activity of an L-asparaginase from Bacillus licheniformis isolated from the Red Sea, Saudi Arabia. Sci Rep, 2019

[13]

Anishkin A, Vanegas JM, Rogers DM, Lorenzi PL, Chan WK, et al.. Catalytic role of the substrate defines specificity of therapeutic L-asparaginase. J Mol Biol, 2015, 427: 2867-2885

[14]

Asselin BLKaspers GJL, Pieters R, Veerman AJP. The three asparaginases. Advances in experimental medicine and biology, 1999, Boston, Springer, 621-629

[15]

Aung H-P, Bocola M, Schleper S, Rohm KH. Dynamics of a mobile loop at the active site of Escherichia coli asparaginase. Biochim Biophys Acta, 2000, 1481: 349-359

[16]

Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, et al.. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children’s Cancer Group study. Blood, 2002, 99: 1986-1994

[17]

Barros RAM, Cristóvão RO, Carabineiro SAC, Neves MC, Freire MG. Immobilization and characterization of L-asparaginase over carbon xerogels. BioTech (Basel), 2022, 11(2): 10

[18]

Bejger M, Imiolczyk B, Clavel D, Gilski M, Pajak A, et al.. Na+/K+ exchange switches the catalytic apparatus of potassium-dependent plant L-asparaginase. Acta Crystallogr D Biol Crystallogr, 2014, 70: 1854-1872

[19]

Borek D, Michalska K, Brzezinski K, Kisiel A, Podkowinski J, et al.. Expression, purification and catalytic activity of Lupinus luteus asparagine β-amidohydrolase and its Escherichia coli homolog. Eur J Biochem, 2004, 271: 3215-3226

[20]

Bosco J, Gagliano E, Boshae KL, Statz JP, Wheeler TB, et al.. A galactose-based auto-expression system improves T7-inducible protein production in Escherichia coli. Sci Rep, 2025, 15: 8936

[21]

Brigitha LJ, Pieters R, van der Sluis IM. How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review. Eur J Cancer, 2021, 157: 238-249

[22]

Broome JD. Studies on the mechanism of tumor inhibition by L-asparaginase: effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells. J Exp Med, 1968, 127: 1055-1072

[23]

Brumano LP, da Silva FVS, Costa-Silva TA, Apolinário AC, Santos JHPM, et al.. Development of L-Asparaginase biobetters: current research status and review of the desirable quality profiles. Front Bioeng Biotechnol, 2019, 6: 212

[24]

CarolinaVieira-Porto A, Cunha SC, Rosa EC, DePaula J, Cruz AG, et al.. Chemical composition and sensory profiling of coffees treated with asparaginase to decrease acrylamide formation during roasting. Food Res Int, 2024

[25]

Cecconello DK, Magalhaes MR, Werlang ICR, Lee MLM, Michalowski MB, et al.. Asparaginase: an old drug with new questions. Transfus Cell Ther, 2020, 42: 275-282

[26]

Chan WK, Tan L, Harutyunyan KG, Du D, Martin LA, et al.. The glutaminase activity of L-asparaginase mediates suppression of Asns upregulation. Blood, 2018, 132(Supplement 1): 3959

[27]

Chan WK, Horvath TD, Tan L, Link T, Harutyunyan KG, et al.. Glutaminase activity of L-asparaginase contributes to durable preclinical activity against acute lymphoblastic leukemia. Mol Cancer Ther, 2019, 18: 1587-1592

[28]

Chohan SM, Rashid N, Sajed M, Imanaka T. Pcal_0970: an extremely thermostable L-asparaginase from Pyrobaculum calidifontis with no detectable glutaminase activity. Folia Microbiol (Praha), 2019, 64: 313-320

[29]

Clark DP, Pazdernik NJ. Chapter 6 - immune technology. Biotechnology, 2016Academic Cell, 181-217

[30]

Cornish-Bowden A. Current IUBMB recommendations on enzyme nomenclature and kinetics. Perspect Sci, 2014, 1: 74-87

[31]

Costa IM, Schultz L, De Araujo Bianchi Pedra B, Leite MSM, Farsky SHP, et al.. Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity. Sci Rep, 2016

[32]

Covino C, Sorrentino A, Pierro DP, Aiello A, Romano R, et al.. Asparaginase enzyme reduces acrylamide levels in fried and wood oven baked pizza base. Food Chem Adv, 2023

[33]

da Costa Alves F, da Silva Rodrigues-Junior V, Cibulski SP. L-Asparaginase bioprospection from Bacillus species. Syst Microbiol Biomanuf, 2026

[34]

da Cunha MC, dos Aguilar JG, Orrillo Lindo SMDR, de Castro RJS, Sato HH. L-asparaginase from Aspergillus oryzae spp.: effects of production process and biochemical parameters. Prep Biochem Biotechnol, 2022, 52: 253-263

[35]

da Ramos RCPS, de Oliveira NS, Bianchini LF, Azevedo-Alanis LR, Pimentel IC, et al.. Cunninghamella echinulata DSM1905 biofilm-based L-asparaginase production in pneumatically-driven bioreactors. PLoS ONE, 2024, 19: e0308847

[36]

Darnal S, Raj R, Chhimwal J, Thakur S, Padwad YS, et al.. Apoptosis and cell cycle arrest of leukemic cells by a robust and stable L-asparaginase from Pseudomonas sp. PCH199. Int J Biol Macromol, 2024

[37]

Darwesh DB, Al-Awthan YS, Elfaki I, Habib SA, Alnour TM, et al.. Anticancer activity of extremely effective recombinant L-asparaginase from Burkholderia pseudomallei. J Microbiol Biotechnol, 2022, 32: 551-563

[38]

Dastmalchi M, Alizadeh M, Jamshidi-Kandjan O, Rezazadeh H, Hamzeh-Mivehroud M, et al.. Expression and biological evaluation of an engineered recombinant L-asparaginase designed by in silico method based on sequence of the enzyme from Escherichia coli. Adv Pharm Bull, 2023, 13: 827-836

[39]

Desai SS, Hungund BS. Submerged fermentation, purification, and characterization of L-asparaginase from Streptomyces sp. isolated from soil. J Appl Biol Biotechnol, 2018, 6: 7-23

[40]

Dias FFG, Santos Aguilar JGdos, Sato HH. L-Asparaginase from Aspergillus spp.: production based on kinetics, thermal stability and biochemical characterization. 3 Biotech, 2019

[41]

Domenech C, Thomas X, Chabaud S, Baruchel A, Gueyffier F, et al.. L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial. Br J Haematol, 2011, 153: 58-65

[42]

Dumina M, Zhgun A, Pokrovskaya M, Aleksandrova S, Zhdanov D, et al.. Highly active thermophilic l-asparaginase from melioribacter roseus represents a novel large group of type II bacterial L-asparaginases from chlorobi-ignavibacteriae-bacteroidetes clade. Int J Mol Sci, 2021

[43]

Dumina M, Zhdanov D, Zhgun A, Pokrovskaya M, Aleksandrova S, et al.. Enhancing the catalytic activity of thermo-asparaginase from Thermococcus sibiricus by a double mesophilic-like mutation in the substrate-binding region. Int J Mol Sci, 2023

[44]

Earl M. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol, 2009, 7: 600-606

[45]

Earl M. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol, 2009, 7: 600-606

[46]

El-Naggar NEA, Deraz SF, El-Ewasy SM, Suddek GM. Purification, characterization and immunogenicity assessment of glutaminase free L-asparaginase from Streptomyces brollosae NEAE-115. BMC Pharmacol Toxicol, 2018

[47]

El-Naggar NEA, Hamouda RA, Elshafey N. Artificial intelligence-based optimization for extracellular L-asparaginase production by Streptomyces violaceoruber. Sci Rep, 2024, 14: 29625

[48]

Elouali A, Mharzi S, Lahrache K, Ghanam A, Babakhouya A, et al.. Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia. Leuk Res Rep, 2023

[49]

Evans R, O’Neill M, Pritzel A, Antropova N, Senior A, et al.. Protein complex prediction with AlphaFold-Multimer. Biorxiv, 2021

[50]

Farahat MG, Amr D, Galal A. Molecular cloning, structural modeling and characterization of a novel glutaminase-free L-asparaginase from Cobetia amphilecti AMI6. Int J Biol Macromol, 2020, 143: 685-695

[51]

Feng Y, Liu S, Jiao Y, Wang Y, Wang M, et al.. Improvement of l-asparaginase thermal stability by regulating enzyme kinetic and thermodynamic states. Process Biochem, 2018, 71: 45-52

[52]

Gervais D, Foote N. Recombinant deamidated mutants of Erwinia chrysanthemi l-asparaginase have similar or increased activity compared to wild-type enzyme. Mol Biotechnol, 2014, 56: 865-877

[53]

Gomes JGdaS, Brandão LC, Pinheiro DP, Pontes LQ, Carneiro RF, et al.. Kinetics characterization of a low immunogenic recombinant L-asparaginase from Phaseolus vulgaris with cytotoxic activity against leukemia cells. Int J Biol Macromol, 2024

[54]

Guardamagna I, Iaria O, Lonati L, Mentana A, Previtali A, et al.. Asparagine and glutamine deprivation alters ionizing radiation response, migration and adhesion of a p53null colorectal cancer cell line. Int J Mol Sci, 2023, 24: 2983

[55]

Hammel P, Fabienne P, Mineur L, Metges JP, Andre T, et al.. Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: an open-label, randomized Phase IIb trial. Eur J Cancer, 2020, 124: 91-101

[56]

Harayama F, Yasuhira H. Effect of glutaminase in rice koji and from Bacillus subtilis GT strain on miso fermentation. J Brew Soc Jpn, 1991, 86: 529-535

[57]

Hawkins DS, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, et al.. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clin Cancer Res, 2004, 10: 5335-5341

[58]

Hendriksen HV, Kornbrust BA, Ostergaard PR, Stringer MA. Evaluating the potential for enzymatic acrylamide mitigation in a range of food products using an asparaginase from Aspergillus oryzae. J Agric Food Chem, 2009, 57: 4168-4176

[59]

Heo YA, Syed YY, Keam SJ. Pegaspargase: a review in acute lymphoblastic leukaemia. Drugs, 2019, 79: 767-777

[60]

Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma, 2015, 57: 748-757

[61]

Hosseini K, Zivari-Ghader T, Dilmaghani A, Akbarzadehlaleh P, Jafarzadeh-Chehraghi E. Review on up and downstream processing of L-asparaginase. Prep Biochem Biotechnol, 2025, 55: 661-669

[62]

Husain I, Sharma A, Kumar S, Malik F. Purification and characterization of glutaminase free asparaginase from enterobacter cloacae: in-vitro evaluation of cytotoxic potential against human myeloid leukemia HL-60 cells. PLoS ONE, 2016

[63]

Jana A, Biswas S, Ghosh R, Modak R. Recent advances in L-Asparaginase enzyme production and formulation development for acrylamide reduction during food processing. Food Chem X, 2024

[64]

Jia R, Wan X, Geng X, Xue D, Xie Z, et al.. Microbial L-asparaginase for application in acrylamide mitigation from food: current research status and future perspectives. Microorganisms, 2021, 9(8): 1659

[65]

Jiao L, Chi H, Xia B, Lu Z, Bie X, et al.. Thermostability ımprovement of L-Asparaginase from Acinetobacter soli via consensus-designed cysteine residue substitution. Molecules, 2022

[66]

Juluri KR, Siu C, Cassaday RD. Asparaginase in the treatment of acute lymphoblastic leukemia in adults: current evidence and place in therapy. Blood Lymphat Cancer, 2022, 12: 55-79

[67]

Kasturiasih N, Ahmad A, Arfah R, Khairunnur S, Soekamto N, et al.. Production, characterization, and toxicity test of L-asparaginase from Vibrio alginolyticus bacterial symbiont of green algae Caulerpa lentillifera. Molekul, 2023, 18: 442-449

[68]

Kidd JG. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med, 1953, 98: 565-582

[69]

Koprivnikar J, McCloskey J, Faderl S. Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia. OncoTargets Ther, 2017, 10: 1413-1422

[70]

Kotzia GA, Labrou NE. L-asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization. J Biotechnol, 2007, 127: 657-669

[71]

Kumar J, Das S, Teoh SL. Dietary acrylamide and the risks of developing cancer: facts to ponder. Front Nutr, 2018

[72]

Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, et al.. Polyethylene glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). J Pediatr Hematol Oncol, 2011, 33: 610-616

[73]

Kwok KK, Vincent EC, Gibson JNDowd FJ, Johnson BS, Mariotti AJ. Antineoplastic drugs. Pharmacology and therapeutics for dentistry, 2017, 7Mosby, 530-562

[74]

Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, et al.. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release, 2009, 139: 182-189

[75]

Lailaja VP, Sumithra TG, Sharma SRK, Mohammed MA, Sivan U, et al.. Tapping the untapped: type II L-asparaginase from marine crustacean-derived Chryseomicrobium amylolyticum as a potential bio better for blood cancer therapy. Sci Rep, 2025, 15: 26759

[76]

Lea PJ, Miflin BJ. Distribution and properties of a potassium-dependent asparaginase isolated from developing seeds of Pisum sativum and other plants. Plant Physiol, 1980, 65: 22-26

[77]

Lima-Solano M, Morales-Ramos V, Gómez-Merino FC, Manson RH, Contreras-Oliva A, et al.. Coffee innovation: global trends and future perspectives. Agrociencia, 2025

[78]

Loch JI, Jaskolski M. Structural and biophysical aspects of L-asparaginases: a growing family with amazing diversity. IUCrJ, 2021, 8: 514-531

[79]

Lomelino CL, Andring JT, McKenna R, Kilberg MS. Asparagine synthetase: function, structure, and role in disease. J Biol Chem, 2017, 292: 19952-19958

[80]

Lubkowski J, Wlodawer A. Geometric considerations support the double-displacement catalytic mechanism of l-asparaginase. Protein Sci, 2019, 28: 1850-1864

[81]

Lubkowski J, Wlodawer A. Structural and biochemical properties of L-asparaginase. FEBS J, 2021, 288: 4183-4209

[82]

Lubkowski J, Vanegas J, Chan WK, Lorenzi PL, Weinstein JN, et al.. Mechanism of catalysis by L-asparaginase. Biochemistry, 2020, 59: 1927-1945

[83]

Lundbeck. ELSPAR (asparaginase). 2013. http://www.accessdata.fda.gov/d%0Arugsatfda_docs/label/2013/101063s5169lbl.pdf. Accessed 18 Apr 2025

[84]

Lynggaard LS, Vaitkeviciene G, Langenskiöld C, Lehmann AK, Lähteenmäki PM. Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia. Br J Haematol, 2022, 197(6): 745-754

[85]

Maggi M, Mittelman SD, Parmentier JH, Colombo G, Meli M, et al.. A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro. Sci Rep, 2017

[86]

Maghraby YR, El-Shabasy RM, Ibrahim AH, Azzazy HME. Enzyme immobilization technologies and industrial applications. ACS Omega, 2023, 8: 5184-5196

[87]

Mahajan RV, Saran S, Kameswaran K, Kumar V, Saxena RK. Efficient production of l-asparaginase from Bacillus licheniformis with low-glutaminase activity: optimization, scale up and acrylamide degradation studies. Bioresour Technol, 2012, 125: 11-16

[88]

Meghavarnam AK, Janakiraman S. Evaluation of acrylamide reduction potential of L-asparaginase from Fusarium culmorum (ASP-87) in starchy products. LWT, 2018, 89: 32-37

[89]

Meneguetti GP, Santos JHPM, Obreque KMT, et al.. Novel site-specific PEGylated L-asparaginase. PLoS ONE, 2019

[90]

Michalska K, Jaskolski M. Structural aspects of L-asparaginases, their friends and relations. Acta Biochim Pol, 2006, 53: 627-640

[91]

Michalska K, Hernandez-Santoyo A, Jaskolski M. The mechanism of autocatalytic activation of plant-type L-asparaginases. J Biol Chem, 2008, 283: 13388-13397

[92]

Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods, 2022

[93]

Mirghasemi S, Pordeli H, Fozouni L, Mina K, Komshikamar F, et al.. Exploring Bacillus subtilis ısolated from soil as a promising alternative for L-asparaginase enzyme production. Health Biotechnol Biopharma, 2023

[94]

Mohamed SA, Elshal MF, Kumosani TA, Aldahlawi AM. Purification and characterization of asparaginase from Phaseolus vulgaris seeds. Evid Based Complem Alternat Med, 2015

[95]

Morais S, Souza T. Human L-asparaginase: acquiring knowledge of its activation (Review). Int J Oncol, 2021

[96]

Mostafa Y, Alrumman S, Alamri S, Hashem M, Al-izran K. Enhanced production of glutaminase-free L-asparaginase by marine Bacillus velezensis and cytotoxic activity against breast cancer cell lines. Electron J Biotechnol, 2019, 42: 6-15

[97]

Mottram DS, Wedzicha BL, Dodson AT. Acrylamide is formed in the Maillard reaction. Nature, 2002, 419: 448-449

[98]

Mousa M, El-Dein MMN, Abou-Dobara MI, Metwally NE. Purification and immobilization of L-asparaginase from Citrobacter freundii EGY-NE1. PREPRINT Res Square, 2021

[99]

Nadeem MS, Khan JA, Al-Ghamdi MA, Khan MI, Zeyadi MA. Studies on the recombinant production and anticancer activity of thermostable L-asparaginase I from Pyrococcus abyssi. Braz J Biol, 2022

[100]

Nguyen HA, Su Y, Lavie A. Design and characterization of Erwinia chrysanthemi l-asparaginase variants with diminished l-glutaminase activity. J Biol Chem, 2016, 291: 17664-17676

[101]

Oettgen HF, Stephenson PA, Schwartz MK, Leeper RD, Tallal L, et al.. Toxicity of E. coli L-asparaginase in man. Cancer, 1970, 25: 253-278

[102]

Onishi Y, Prihanto AA, Yano S, Takagi K, Umekawa M, et al.. Effective treatment for suppression of acrylamide formation in fried potato chips using L-asparaginase from Bacillus subtilis. 3 Biotech, 2015, 5: 783-789

[103]

Patel N, Krishnan S, Offman MN, Krol M, Moss CX, et al.. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. J Clin Invest, 2009, 119: 1964-1973

[104]

Pedreschi F, Kaack K, Granby K. Reduction of acrylamide formation in potato slices during frying. LWT, 2004, 37: 679-685

[105]

Pedroso A, Herrera Belén L, Beltrán JF, Castillo RL, Pessoa A, et al.. In silico design of a chimeric humanized L-asparaginase. Int J Mol Sci, 2023, 24: 7550

[106]

Pham JV, Yilma MA, Feliz A, Majid MT, Maffetone N, et al.. A review of the microbial production of bioactive natural products and biologics. Front Microbiol, 2019, 10: 1404

[107]

Richards NG, Kilberg MS. Asparagine synthetase chemotherapy. Annu Rev Biochem, 2006, 75: 629-654

[108]

Rigouin C, Nguyen HA, Schalk AM, Lavie A. Discovery of human-like L-asparaginases with potential clinical use by directed evolution. Sci Rep, 2017

[109]

Roohvand F, Shokri M, Abdollahpour-Alitappeh M, Ehsani P. Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines. Expert Opin Ther Pat, 2017, 27: 929-951

[110]

Rosales-Mendoza S, Angulo C. Bacillus subtilis comes of age as a vaccine production host and delivery vehicle. Expert Rev Vaccines, 2015, 14: 1135-1148

[111]

Ross GD (2014) Cancer therapy using beta glucan and antibodies. University of Louisville Research Foundation, Inc. (Louisville, KY, US), assignee. Patent US20150064199A1 (EP2181711A1).

[112]

Saeed H, Hemida A, Abdel-Fattah M, Eldoksh A, Shalaby M, et al.. Pseudomonas aeruginosa recombinant L-asparaginase: large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines. Protein Expr Purif, 2021, 181: 105820

[113]

Safary A, Moniri R, Hamzeh-Mivehroud M, Dastmalchi S. Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain. Bioimpacts, 2019, 9: 15-23

[114]

Salzer WL, Asselin BL, Plourde PV, Corn T, Hunger SP. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia. Ann N Y Acad Sci, 2014, 1329: 81-92

[115]

Schalk AM, Lavie A. Structural and kinetic characterization of guinea pig L-asparaginase type III. Biochemistry, 2014, 53: 2318-2328

[116]

Shafqat I, Shahzad S, Yasmin A, Chaudhry MT, Ahmed S, et al.. Characterization and applications of glutaminase free L-asparaginase from indigenous Bacillus halotolerans ASN9. PLoS ONE, 2023

[117]

Shakambari G, Sameer Kumar R, Ashokkumar B, Ganesh V, Vasantha VS, et al.. Cloning and expression of L-asparaginase from Bacillus tequilensis PV9W and therapeutic efficacy of Solid Lipid Particle formulations against cancer. Sci Rep, 2018

[118]

Sharafi Z, Barati M, Khoshayand MR, Adrangi S. Screening for Type II L-Asparaginases: lessons from the Genus Halomonas. Iran J Pharm Res, 2017, 16: 1565-1573

[119]

Sindhu R, Manonmani HK. Expression and characterization of recombinant L-asparaginase from Pseudomonas fluorescens. Protein Expr Purif, 2018, 143: 83-91

[120]

Sindhu R, Shiburaj S, Sabu A, Fernandes P, Singhal, et al.Kai K, Kasiviswanathan M, et al.. Enzyme technology in food processing: recent developments and future prospects. Enzyme technology in food processing: recent developments and future prospects. Innovative Food Processing Technologies, 2020Elsevier, 191-215

[121]

Sivasankari M, Tariq AL, Amutha R. Role of asparaginase enzyme in food processing industry to reduce the acrylamide level-a review. Int J Recent Sci Res, 2018, 9: 27660-27664

[122]

Stier H, Ebbeskotte V, Gruenwald J. Immune-modulatory effects of dietary yeast beta-1,3/1,6-D-glucan. Nutr J, 2014, 13: 38

[123]

Strzelczyk P, Zhang D, Alexandratos J, Piszczek G, Wlodawer A, et al.. The dimeric form of bacterial l-asparaginase YpAI is fully active. FEBS J, 2023, 290: 780-795

[124]

Suman DK, Kodavaty J, Kakara D, Mallu MR, Erva RR. Production strategies and applications of L-asparaginase. Res J Biotechnol, 2024, 19: 193-215

[125]

Szymanska B, Wilczynska-Kalak U, Kang MH, Liem NL, Carol H, et al.. Pharmacokinetic modelling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts. PLoS ONE, 2012

[126]

Tripathi NK, Shrivastava A. Recent developments in bioprocessing of recombinant proteins: expression hosts and process development. Front Bioeng Biotechnol, 2019, 7: 420

[127]

Tsegaye K, Tsehai BA, Getie B. Desirable L-asparaginases for treating cancer and current research trends. Front Microbiol, 2024

[128]

Ueno T, Ohtawa K, Mitsui K, Kodera Y, Hiroto M, et al.. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia, 1997, 11: 1858-1861

[129]

Vadala BS, Deshpande S, Apte-Deshpande A. Soluble expression of recombinant active cellulase in E.coli using B.subtilis (natto strain) cellulase gene. J Genet Eng Biotechnol, 2021, 19: 7

[130]

Verma N, Kumar K, Kaur G, Anand S. L-asparaginase: a promising chemotherapeutic agent. Crit Rev Biotechnol, 2007, 37: 45-62

[131]

Verma S, Mehta RK, Maiti P, Röhm KH, Sonawane A. Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II. Biochim Biophys Acta, 2014, 1844: 1219-1230

[132]

Vo TD, Sulaiman C, Tafazoli S, Lynch B, Roberts A, et al.. Safety assessment of glutaminase from Aspergillus niger. Food Sci Nutr, 2020, 8: 1433-1450

[133]

Vrooman LM, Supko JG, Neuberg DS, AsselinAthale BL, et al.. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer, 2010, 54: 199-205

[134]

Watanabe A, Inukai T, Tamai M, Shinohara T, Somazu S, et al.. Involvement of allele-specific methylation of asparagine synthetase gene in asparaginase sensitivity of BCP-ALL. Blood, 2016

[135]

Xu F, Oruna-Concha M-J, Elmore JS. The use of asparaginase to reduce acrylamide levels in cooked food. Food Chem, 2016, 210: 163-171

[136]

Yun M-K, Nourse A, White SW, Rock CO, Heath RJ. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I. J Mol Biol, 2007, 3: 794-811

[137]

Zhou Y, Jiao L, Shen J, Chi H, Lu Z, Liu H, Lu F, Zhu P. Enhancing the catalytic activity of type II L-asparaginase from Bacillus licheniformis through semi-rational design. Int J Mol Sci, 2022

[138]

Zhou R, Liang T, Li T, Huang J, Chen C. Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia. Front Oncol, 2023

[139]

Zielezinski A, Loch JI, Karlowski WM, Jaskolski M. Massive annotation of bacterial l-asparaginases reveals their puzzling distribution and frequent gene transfer events. Sci Rep, 2022

[140]

Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, et al.. Safety evaluation of the food enzyme asparaginase from the non-genetically modified Saccharomyces cerevisiae strain ARY-2. EFSA J, 2025, 23: e9532

[141]

Zuo S, Zhang T, Jiang B, Mu W. Reduction of acrylamide level through blanching with treatment by an extremely thermostable L-asparaginase during French fries processing. Extremophiles, 2015, 19: 841-851

Rights & permissions

Jiangnan University

PDF

12

Accesses

0

Citation

Detail

Sections
Recommended

/